V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220002284 | 220006935 | 1.71 | 47 | Palliative (P) | 2017-11-04 | 2017-12-17 | null | 02 | N | BEVACIZUMAB + IRINOTECAN | 100924742 |
| 220002285 | 220006936 | null | null | null | null | 2018-09-21 | null | null | null | CARBOPLATIN + VINCRISTINE | 100978406 |
| 220002296 | 220006941 | null | null | null | null | 2020-01-20 | null | null | null | TEMOZOLOMIDE + RT | 101813625 |
| 220002298 | 220006942 | null | null | null | null | 2019-01-04 | Carboplatin AUC 2 - 5 | null | null | VINBLASTINE | 100075927 |
| 220002300 | 220006943 | null | null | Curative (C) | 2016-07-04 | 2016-07-11 | CNS High Grade Glioma PCV | 02 | N | BEVACIZUMAB + IRINOTECAN | 101790400 |
| 220002305 | 220006946 | 1.63 | 98 | Palliative (P) | 2019-08-01 | 2019-08-05 | CNS VINILO (trial) wkly Vinblastine/Nilotinib | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100286917 |
| 220002322 | 220006957 | 1.61 | 77 | null | null | 2019-05-27 | PCV | null | null | CNS LGG2004 03 VINC + CARBO | 101746795 |
| 220002326 | 220006960 | 1.58 | 125.5 | Palliative (P) | 2016-04-03 | 2016-04-03 | null | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100107554 |
| 220002327 | 220006961 | null | null | null | null | 2017-05-10 | Carboplatin AUC 2 - 5 | null | null | LOMUSTINE | 100665222 |
| 220002335 | 220006968 | null | null | Palliative (P) | 2018-04-07 | 2018-04-07 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101206360 |
| 220002339 | 220006972 | 1.44 | 97.5 | Palliative (P) | 2016-11-15 | 2016-12-05 | null | 02 | N | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100413056 |
| 220002344 | 220006974 | 1.61 | 68.45 | null | null | 2019-07-05 | Carboplatin AUC 2 - 5 | null | null | CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE | 100567338 |
| 220002357 | 220006978 | 1.8 | 54.8 | Curative (C) | 2017-12-29 | 2018-01-05 | null | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100211457 |
| 220002362 | 220006980 | 1.72 | 61.3 | Adjuvant (A) | 2014-09-06 | 2016-07-17 | null | 02 | N | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100564011 |
| 220002363 | 220006981 | null | null | Palliative (P) | 2017-04-22 | 2017-06-17 | Ipilimumab | 02 | N | CNS LOW GRADE GLIOMA TPCV | 101538547 |
| 220002378 | 220006991 | null | null | null | null | 2017-08-10 | CNS LGG2004 03 vinc + carbo | null | null | BEVACIZUMAB + IRINOTECAN | 101446672 |
| 220002388 | 220006998 | null | null | Adjuvant (A) | 2019-07-24 | 2019-08-13 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE + RT | 101379806 |
| 220002389 | 220006999 | 1.72 | 85.6 | null | null | 2018-05-04 | null | null | null | CNS HGG TEMOZOLOMIDE +XRT | 100207972 |
| 220002390 | 220007000 | 0 | 91.4 | Curative (C) | null | 2017-09-21 | Bevacizumab + Temozolomide | 01 | Y | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100407527 |
| 220002398 | 220007005 | 0 | 87 | null | null | 2018-02-25 | Temozolomide + RT | null | null | TEMOZOLOMIDE + RT | 100255953 |
| 220002400 | 220007006 | null | null | null | null | 2019-05-16 | CNS High Grade Glioma PCV | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101633687 |
| 220002408 | 220007009 | null | null | null | null | 2018-12-28 | PCV | null | null | CNS EPENDY II VINC/CARBO | 101236757 |
| 220002415 | 220007014 | null | null | null | null | 2017-04-17 | null | null | null | TRIAL UNSPECIFIED | 101336307 |
| 220002418 | 220007017 | null | null | Curative (C) | 2016-12-16 | 2017-01-05 | null | 02 | N | PCV | 101736629 |
| 220002423 | 220007019 | 1.58 | 96.9 | null | null | 2018-07-07 | null | null | null | CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE | 100753727 |
| 220002426 | 220007021 | 1.73 | 64.9 | null | null | 2019-06-07 | null | null | null | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 101655699 |
| 220002440 | 220007028 | null | null | Curative (C) | 2018-11-25 | 2018-11-25 | null | 02 | N | BEVACIZUMAB + IRINOTECAN | 100599039 |
| 220002441 | 220007029 | 1.82 | 62 | Curative (C) | 2016-05-27 | 2016-06-24 | PCV | 02 | N | CNS LGG2004 03 VINC + CARBO | 101008374 |
| 220002442 | 220007030 | null | null | null | null | 2019-08-23 | Trial Unspecified | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100830260 |
| 220002452 | 220007034 | 0 | 11 | null | null | 2017-11-25 | Lomustine | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101073201 |
| 220002460 | 220007037 | 1.78 | 68.7 | null | null | 2017-01-09 | CNS LGG 2004 03 vinc weekly+ carbo | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100597739 |
| 220002461 | 220007038 | 1.48 | 93.2 | Adjuvant (A) | 2019-12-14 | 2019-12-21 | Trial Unspecified | 02 | Y | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 101663683 |
| 220002466 | 220007041 | 1.61 | 30.7 | Palliative (P) | 2016-11-13 | 2017-07-02 | null | 02 | N | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100809338 |
| 220002469 | 220007044 | null | null | Palliative (P) | 2016-11-28 | 2016-11-29 | Trial Unspecified | 02 | N | PACKER MAINTENANCE REGIMEN | 100672866 |
| 220002470 | 220007045 | null | null | null | null | 2017-06-18 | CNS LGG 2004 03 cons vinc + carbo | null | null | CNS MEDBL SR | 100074235 |
| 220002480 | 220007049 | 1.68 | 73 | Palliative (P) | 2017-04-30 | 2017-04-30 | null | 02 | N | BEVACIZUMAB + IRINOTECAN | 101579798 |
| 220002481 | 220007050 | null | null | null | null | 2017-06-25 | PCV | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100870129 |
| 220002485 | 220007054 | null | null | Palliative (P) | 2017-06-11 | 2018-05-05 | CNS LGG 2004 03 vinc weekly+ carbo | 02 | null | CNS EPENDY II VEC | 100763928 |
| 220002487 | 220007055 | null | null | null | 2020-11-23 | 2020-12-06 | Lomustine | 02 | null | PCV | 101663910 |
| 220002489 | 220007056 | 1.73 | 73.9 | Palliative (P) | 2016-12-31 | 2017-02-17 | PCV | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101191734 |
| 220002492 | 220007057 | null | null | null | 2016-06-01 | 2016-06-01 | null | 02 | null | PCV | 100545966 |
| 220002501 | 220007062 | 1.72 | 75 | Palliative (P) | 2016-05-03 | 2016-07-12 | PCV | 01 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101372338 |
| 220002502 | 220007063 | null | null | Curative (C) | 2017-03-04 | 2017-11-13 | PCV | 02 | N | CNS HGG TEMOZOLOMIDE MAINTENANCE | 101111551 |
| 220002506 | 220007066 | null | null | null | null | 2019-10-11 | Lomustine | null | null | IPILIMUMAB | 100745292 |
| 220002508 | 220007067 | null | null | Palliative (P) | 2017-06-17 | 2017-06-21 | Temozolomide + RT | 01 | N | TEMOZOLOMIDE + RT | 100556279 |
| 220002510 | 220007069 | 1.71 | 75 | Palliative (P) | null | 2017-01-08 | null | 02 | N | CNS LGG 2004 03 CON VINC + CISPLATIN | 100559980 |
| 220002513 | 220007070 | 1.66 | 75 | null | null | 2017-07-11 | PCV | null | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101041897 |
| 220002519 | 220007074 | null | null | null | null | 2018-12-04 | CNS Low Grade Glioma Vinblastine | null | null | IPILIMUMAB | 100264488 |
| 220002524 | 220007076 | 1.71 | 6.89 | null | 2016-04-10 | 2016-04-10 | null | 02 | null | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 100752330 |
| 220002525 | 220007077 | null | null | null | 2019-11-02 | 2019-11-20 | Trial Unspecified | 02 | null | CNS LGG2004 03 VINC + CARBO | 101411388 |